Signature Diagnostics AG

Signature Diagnostics AG

Signature Diagnostics AG

Date Founded



Hermannswerder 20A,Potsdam, Brandenburg 14473

Type of Company




Company Description

Signature Diagnostics AG operates as a molecular diagnostics company. It discovers, validates and develops novel diagnostic products that predict outcome and drug response in patients with colorectal cancer, non-small cell lung cancer and ovarian cancer. The company was founded by André Rosenthal in 2004 and is headquartered in Potsdam, Germany.

Executives & Employees

Co-Chief Executive Officer

Director-Information Technology

Paths to Signature Diagnostics AG
Potential Connections via
Relationship Science
Signature Diagnostics AG
Recent Transactions
Details Hidden

Roche Holding AG purchases Signature Diagnostics AG from KfW Mittelstandsbank, EVP Capital Management, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, BC Brandenburg Capital GmbH

Details Hidden

MDxHealth SA purchases Signature Diagnostics AG

Transaction Advisors
Legal Advisor

Advised onMDxHealth SA purchases Signature Diagnostics AG

Details Hidden

KfW Mittelstandsbank invests in young technology-based businesses and established small and medium-sized companies.The ERP Start fund is invested in early-stage innovative businesses, generally in syndication with a third-party investment firm, a corporate strategic investor, the German Federal Ministry for Economics and Labor (BMWA) and private investors. The firm co-invests with a lead investor who provides consulting support to the investee. They avoid getting involved in the management of the companies in which they invest. The firm may participate in subsequent financing rounds. The ERP Start fund is focused on technology-based startups developing new products or services based on their own research and development effort.The ERP Participation program makes one-time only investments in direct equity participations, targeting established middle-market companies with an annual turnover of up to 50 million Euros. ERP Participation focuses on expansion financing, operational restructuring, corporate successions, shareholder restructuring and innovative or cooperative projects. The targeted investment horizon varies from 10 years in the western part of Germany to 15 years in the eastern regions.The KfW Unternehmerkapital program specializes in mezzanine financing, offering long-term subordinated loans to startups, expansion-phase businesses and established companies.

Details Hidden

Co-Chief Executive Officer at Signature Diagnostics AG

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Signature Diagnostics AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Signature Diagnostics AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Signature Diagnostics AG.
  • be_ixf; php_sdk; php_sdk_1.4.15